They were trying to do a IPO not long ago, the pharma market was in a rough patch then. They were trying for a $50 million IPO
BioCardia was founded in 2002 and booked $1 million in sales for the 12 months ended March 31, 2015. It had planned to list on the Nasdaq under the symbol "BCDA," according to Renaissance Capital.